Company
Acasti Pharma Inc.
5 Legal Matters
0
4
1
OverviewLitigationPatentsTrademarksStatisticsNews

Acasti Pharma Inc. Company IP News and Updates

Warren Woessner
•
Nalproprion v. Actavis: WDR met by Substantially Equivalent Claim Elements(?)
Warren Woessner
•
Aug 29, 2019
In Nalproprion v Actavis, App. No. 2018-1221 (Fed. Cir., August 15, 2019) a divided panel of Judges Prost, Lourie and...
Read More
Showing 1-1 of 1 news found